Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Shares Issued: 2019-2024

Historic Shares Issued for Nurix Therapeutics (NRIX) over the last 6 years, with Nov 2024 value amounting to $289.8 million.

  • Nurix Therapeutics' Shares Issued fell 97.67% to $977,000 in Q3 2025 from the same period last year, while for Aug 2025 it was $137.8 million, marking a year-over-year increase of 48.93%. This contributed to the annual value of $289.8 million for FY2024, which is 12899.69% up from last year.
  • Nurix Therapeutics' Shares Issued amounted to $289.8 million in FY2024, which was up 12,899.69% from $2.2 million recorded in FY2023.
  • Nurix Therapeutics' Shares Issued's 5-year high stood at $289.8 million during FY2024, with a 5-year trough of $2.2 million in FY2023.
  • In the last 3 years, Nurix Therapeutics' Shares Issued had a median value of $94.8 million in 2022 and averaged $128.9 million.
  • As far as peak fluctuations go, Nurix Therapeutics' Shares Issued surged by 153,524.65% in 2020, and later slumped by 97.65% in 2023.
  • Nurix Therapeutics' Shares Issued (Yearly) stood at $218.1 million in 2020, then plummeted by 31.17% to $150.2 million in 2021, then plummeted by 36.89% to $94.8 million in 2022, then crashed by 97.65% to $2.2 million in 2023, then spiked by 12,899.69% to $289.8 million in 2024.